The impact of healthcare-associated infections on COVID-19 mortality: a cohort study from a Brazilian public hospital
Authors:
- Bruna Cuoco ProvenzanoBPBruna Cuoco Provenzano
- Thiago BartholoTBThiago Bartholo
- Marcelo Ribeiro-AlvesMRMarcelo Ribeiro-Alves
- Ana Paula Gomes dos SantosASAna Paula Gomes dos Santos
- Thiago Thomaz MafortTMThiago Thomaz Mafort
- Marcos Cesar Santos de CastroMCMarcos Cesar Santos de Castro
- Jose Gustavo Pugliese de OliveiraJOJose Gustavo Pugliese de Oliveira
- Leonardo Palermo BrunoLBLeonardo Palermo Bruno
- Agnaldo José LopesAgnaldo José Lopes
- Claudia Henrique da CostaCCClaudia Henrique da Costa
- Rogerio RufinoRRRogerio Rufino
Open Access
- 1 July 2021
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 67 (7) , 997-1002
Abstract
OBJECTIVE: This study aims to analyze the risk factors for in-hospital mortality in a cohort of patients admitted to a newly adapted intensive care unit in a public hospital in Rio de Janeiro. METHODS: This was an observational, retrospective, and descriptive study. Data were obtained from electronic medical records. Coronavirus disease 2019 (COVID-19) was diagnosed by detecting viral ribonucleic acid using reverse transcription polymerase chain reaction. Factors associated with the risk/protection from death were determined using the odds ratio and adjusted odds ratio. RESULTS: Fifty-one patients were admitted to the hospital. The median age of the patients was 63 years, 60% were male patients, and 54% were white patients. Sixty-seven percent of the patients were diagnosed with COVID-19. Sepsis at admission increased the chance of in-hospital death by 21 times (adjusted odds ratio=21.06 [0.79-555.2]; p=0.06). The strongest risk factor for death was the development of septic shock during hospitalization (adjusted odds ratio=98.56 [2.75-352.5]; p=0.01), and one in four patients had multidrug-resistant bacteria. Mechanical ventilation, vasopressors, neuromuscular blockers, and sedatives were also the risk factors for in-hospital mortality. The in-hospital mortality rate was 41%, and the mortality rate of patients on mechanical ventilation was 60%. The diagnosis of COVID-19 was not statistically related to the adverse outcomes. CONCLUSIONS: In this cohort, the strongest risk factor for in-hospital death was the development of nosocomial septic shock. Healthcare-associated infections have a significant impact on mortality rates. Therefore, to have a better outcome, it is important to consider not only the availability of beds but also the way healthcare is delivered.Keywords
This publication has 14 references indexed in Scilit:
- COVID-19 infection: Emergence, transmission, and characteristics of human coronavirusesJournal of Advanced Research, 2020
- Managing ICU surge during the COVID-19 crisis: rapid guidelinesIntensive Care Medicine, 2020
- Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysisThe Lancet, 2020
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City AreaJAMA, 2020
- Recent progress on the diagnosis of 2019 Novel CoronavirusTransboundary and Emerging Diseases, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019New England Journal of Medicine, 2020
- Improving ICU services in resource-limited settings: Perceptions of ICU workers from low-middle-, and high-income countriesJournal of Critical Care, 2018
- Quality Improvement Initiatives in Sepsis in an Emerging Country: Does the Institution’s Main Source of Income Influence the Results? An Analysis of 21,103 Patients*Critical Care Medicine, 2017
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Differences in Sepsis Treatment and Outcomes between Public and Private Hospitals in Brazil: A Multicenter Observational StudyPLOS ONE, 2013